Industry

POTOMAC, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.” The original patent application was initiated … [Read more…]

VALENCIA, Spain–(BUSINESS WIRE)–BioBam announced last week the release of OmicsBox 2.2. This new version of BioBam’s bioinformatics solution offers new Single Cell and Long Read Data Analysis Features among other platform improvements. These new additions allow the researchers to use the latest sequencing technologies for their genomics and transcriptomics studies. Dr. Stefan Götz, CEO said: … [Read more…]

– Neflamapimod demonstrates that it reverses the neurodegenerative process in the basal forebrain cholinergic system in animal models – – Phase 2a data in Dementia with Lewy Bodies show positive effects of neflamapimod on clinical endpoints associated with cholinergic neuronal function – – EIP Pharma plans initiation of confirmatory Phase 2b clinical trial for DLB … [Read more…]

Nearly 350 people traveled 275 miles over three days to support The Lesbian, Gay, Bisexual & Transgender Community Center’s HIV/AIDS services NEW YORK–(BUSINESS WIRE)–Today, New York City’s Lesbian, Gay, Bisexual & Transgender Community Center (“The Center”) announced that Cycle for the Cause raised over $1.6 million to sustain its HIV/AIDS prevention, education, and support services. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product and Application” report has been added to ResearchAndMarkets.com’s offering. The travel vaccines market in North America is expected to grow from US$ 1,276.32 million in 2021 to US$ 2,503.59 million by 2028; it is estimated to grow … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Contract Pharmaceutical Manufacturing Market, by Service Type, by Molecule Type, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Pharmaceutical companies are now pushing hard to reduce overall manufacturing and research costs by outsourcing various processes related to research, development and manufacturing. … [Read more…]

Health economics study estimates significant savings for England’s NHS OXFORD, England–(BUSINESS WIRE)–#AIH–A health economic study performed by NHS England’s Oxford Academic Health Science Network (AHSN) showed that Perspectum’s LiverMultiScan – an artificial intelligence-enhanced, noninvasive liver health diagnostic tool – is a cost-effective alternative to painful, invasive liver biopsies for monitoring disease activity and treatment response … [Read more…]

LONDON–(BUSINESS WIRE)–All Seas Capital Fund I (“All Seas Capital”), a pan-European private capital fund that provides transformational capital solutions to leading founder- and entrepreneur-owned companies, announces a significant minority investment in Zimmer MedizinSysteme (“Zimmer” or the “Company”), one of the leading manufacturers of physiotherapy and aesthetics devices. A German family run business with over 50 … [Read more…]

ATLANTA–(BUSINESS WIRE)–#Biotech–Axion BioSystems today announces Maestro TrayZ, an innovative, live-cell analysis platform designed for high-throughput drug development and therapeutic discovery. The new system—featuring a slim multiplate tray design that allows for modular scalability and fits comfortably inside an incubator—joins Axion’s growing suite of next-generation Maestro products and offers a flexible, affordable option for noninvasive, label-free … [Read more…]

Positive results from Phase 2 NASH Trial (DESTINY-1) for PXL065 reported: Primary efficacy endpoint met: PXL065-treated patients achieved statistically significant improvements in the relative decrease in liver fat content at 36-weeks for all doses Paired liver biopsies confirmed strong improvement of fibrosis and other parameters PXL065 was observed to be safe and well tolerated with … [Read more…]